Abiopharma

News list

Director Dar Zavain 🟢 acquired 3.6K shares of RECURSION PHARMACEUTICALS, INC. (RXRX) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text

News bot Jan. 7, 2026, 12:14 a.m.
🔍 Dar Zavain (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 3,571
Detailed Transactions and Holdings:
- Acquired 3,571 shares of Class A Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 142,329.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.